Intelligent Bio Solutions Inc. (INBS) Cash & Equivalents (2020 - 2025)

Intelligent Bio Solutions' Cash & Equivalents history runs 6 years deep, the most recent figure standing at $1.0 million for Q2 2025.

• In Q2 2025, Cash & Equivalents changed N/A year-over-year to $1.0 million; the TTM figure through Jun 2025 stood at $1.0 million (changed N/A YoY), while the FY2025 annual figure was $1.0 million, changed N/A from the prior year.
• Cash & Equivalents for Q2 2025 stood at $1.0 million, down from $2.8 million in the prior quarter.
• The five-year high for Cash & Equivalents was $14.3 million in Q1 2021, with the low at $1.0 million in Q2 2025.
• The 5-year median for Cash & Equivalents is $5.7 million (2022), against an average of $7.0 million.
• The sharpest annual moves came in 2021 and 2023: Cash & Equivalents jumped 2842.78% in 2021, then slumped 78.8% in 2023.
• Intelligent Bio Solutions' Cash & Equivalents stood at $11.2 million in 2021, then slumped by 73.98% to $2.9 million in 2022, then decreased by 21.68% to $2.3 million in 2023, then declined by 1.78% to $2.2 million in 2024, then slumped by 54.47% to $1.0 million in 2025.
• Business Quant data shows INBS's Cash & Equivalents at $1.0 million in Q2 2025, $2.8 million in Q1 2025, and $2.2 million in Q4 2024.